OPKO HEALTH INC.

Inactive Instrument

Analyst Reco. Opko Health Inc. Nyse

Equities

US68375N1037

Real-time Estimate Cboe BZX Other stock markets 16:12:31 09/05/2024 BST
1.255 ^USD	0.00%

05-07	Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	MT
05-07	OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating	02-28	MT
Barrington Upgrades OPKO Health to Outperform From Market Perform, Price Target is $2	29/06/23	MT
The American consumer comes to the rescue	28/06/23
HC Wainwright Initiates Coverage on OPKO Health With Buy Rating, $3 Price Target	15/12/22	MT
Piper Sandler Adjusts OPKO Health's Price Target to $4 From $5, Reiterates Overweight Rating	05/08/22	MT
Piper Sandler Adjusts OPKO Health's Price Target to $5 From $6, Reiterates Overweight Rating	10/05/22	MT
Barrington Research Downgrades Opko Health Inc to Market Perform From Outperform	24/01/22	MT
OPKO HEALTH : Barrington Adjusts Price Target on Opko Health to $6 From $8 on Lab Unit Revenue Decline, Maintains Outperform Rating	30/07/21	MT
OPKO HEALTH : Ladenburg Thalmann Starts Opko Health at Buy With $7 Price Target	21/06/21	MT
OPKO Health, Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Revenue Guidance for Third Quarter of 2018; Reaffirms Tax Rate Guidance for the Full Year 2018	07/08/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer